Screening for depression in adult patients in primary care settings: A systematic evidence review

Annals of Internal Medicine

Volumn 151, Issue 11, 2009, Pages 793-803

  O'Connor, Elizabeth A ^a   Whitlock, Evelyn P ^a   Beil, Tracy L ^a   Gaynes, Bradley N ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ADVERSE OUTCOME; AGED; CASE MANAGEMENT; CLINICAL TRIAL; DEPRESSION; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; GASTROINTESTINAL HEMORRHAGE; HUMAN; LOW DRUG DOSE; MENTAL DISEASE; META ANALYSIS; POSTMARKETING SURVEILLANCE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEEDBACK; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT CARE TEAM; PRIMARY HEALTH CARE; PSYCHOTHERAPY; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SUICIDE; YOUNG ADULT;

EID: 71749121885     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-151-11-200912010-00007     Document Type: Review

References (83)

1. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005;62:1097-1106 [PMID: 16203955]
2. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627 [PMID: 15939839] (Pubitemid 40973437)
3. Lyness JM, Caine ED, King DA, Cox C, Yoediono Z. Psychiatric disorders in older primary care patients. J Gen Intern Med. 1999;14:249-254 [PMID: 10203638] (Pubitemid 29196428)
4. Schulberg HC, Mulsant B, Schulz R, Rollman BL, Houck PR, Reynolds CF 3rd. Characteristics and course of major depression in older primary care patients. Int J Psychiatry Med. 1998;28:421-436 [PMID: 10207741] (Pubitemid 29144682)
5. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA. 2003;289:3095-3105 [PMID: 12813115]
6. Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526-531 [PMID: 9480363] (Pubitemid 28113431)
7. Harman JS, Veazie PJ, Lyness JM. Primary care physician office visits for depression by older Americans. J Gen Intern Med. 2006;21:926-930 [PMID: 16918736]
8. Gaynes BN, Rush AJ, Trivedi M, Wisniewski SR, Balasubramani GK, Spencer DC, et al. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. Gen Hosp Psychiatry. 2005;27:87-96. [PMID: 15763119] (Pubitemid 40348772)
9. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, Spencer DC, et al. Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis. Ann Fam Med. 2007;5:126-134 [PMID: 17389536]
10. Gilbody S, House AO, Sheldon TA. Screening and case finding instruments for depression. Cochrane Database Syst Rev. 2005:CD002792. [PMID: 16235301]
11. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA. 2003;289:3145-3151 [PMID: 12813120] (Pubitemid 37432890)
12. Coyne JC, Palmer SC, Sullivan PA. Screening for depression in adults [Letter]. Ann Intern Med. 2003;138:767. [PMID: 12729435]
13. Hickie IB, Davenport TA, Ricci CS. Screening for depression in general practice and related medical settings. Med J Aust. 2002;177 Suppl:S111-6. [PMID: 12358569]
14. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-776 [PMID: 12020146]
15. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al; Methods Work Group, Third US Preventive Services Task Force. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21-35. [PMID: 11306229]
16. Whitlock EP, O'Connor E, Beil T, Gaynes B. Screening for Depression in Adults and Older Adults in Primary Care: An Updated Systematic Review. 2009. Agency for Healthcare Research and Quality. Accessed at www.ahrq.gov/clinic/ uspstf/uspstopics.htm on 24 September 2009.
17. Pirraglia PA, Stafford RS, Singer DE. Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care. Prim Care Companion J Clin Psychiatry. 2003;5:153-157. [PMID: 15213776]
18. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med. 2005;143:415-426 [PMID: 16172440] (Pubitemid 41341413)
19. National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: NICE; 2004. Accessed at www.nice.org.uk/nicemedia/pdf/ CG23fullguideline.pdf on 24 September 2009.
20. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44:1271-1278 [PMID: 1834807]
21. Williams JW Jr, Mulrow CD, Kroenke K, Dhanda R, Badgett RG, Omori D, et al. Case-finding for depression in primary care: a randomized trial. Am J Med. 1999;106:36-43. [PMID: 10320115] (Pubitemid 29077701)
22. Rost K, Nutting P, Smith J, Werner J, Duan N. Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med. 2001;16:143-149 [PMID: 11318908]
23. Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-220 [PMID: 10634337] (Pubitemid 30039221)
24. Whooley MA, Stone B, Soghikian K. Randomized trial of case-finding for depression in elderly primary care patients. J Gen Intern Med. 2000;15:293-300. [PMID: 10840264] (Pubitemid 30333826)
25. Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney WM. Improving treatment of late life depression in primary care: a randomized clinical trial. J Am Geriatr Soc. 1994;42:839-846 [PMID: 8046193]
26. Bergus GR, Hartz AJ, Noyes R Jr, Ward MM, James PA, Vaughn T, et al. The limited effect of screening for depressive symptoms with the PHQ-9 in rural family practices. J Rural Health. 2005;21:303-309 [PMID: 16294652] (Pubitemid 41346044)
27. Jarjoura D, Polen A, Baum E, Kropp D, Hetrick S, Rutecki G. Effectiveness of screening and treatment for depression in ambulatory indigent patients. J Gen Intern Med. 2004;19:78-84. [PMID: 14748864] (Pubitemid 38221955)
28. Bosmans J, de Bruijne M, van Hout H, van Marwijk H, Beekman A, Bouter L, et al. Cost-effectiveness of a disease management program for major depression in elderly primary care patients. J Gen Intern Med. 2006;21:1020-1026 [PMID: 16836625] (Pubitemid 44337729)
29. Rubenstein LZ, Alessi CA, Josephson KR, Trinidad Hoyl M, Harker JO, Pietruszka FM. A randomized trial of a screening, case finding, and referral system for older veterans in primary care. J Am Geriatr Soc. 2007;55:166-174 [PMID: 17302651] (Pubitemid 46184390)
30. Wells K, Sherbourne C, Schoenbaum M, Ettner S, Duan N, Miranda J, et al. Five-year impact of quality improvement for depression: results of a group-level randomized controlled trial. Arch Gen Psychiatry. 2004;61:378-386 [PMID: 15066896] (Pubitemid 38451547)
31. Sherbourne CD, Wells KB, Duan N, Miranda J, Unützer J, Jaycox L, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001;58:696-703. [PMID: 11448378] (Pubitemid 32640866)
32. Rost K, Nutting PA, Smith J, Werner JJ. Designing and implementing a primary care intervention trial to improve the quality and outcome of care for major depression. Gen Hosp Psychiatry. 2000;22:66-77. [PMID: 10822094] (Pubitemid 30259156)
33. Rost K, Nutting P, Smith JL, Elliott CE, Dickinson M. Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care. BMJ. 2002;325:934-937 [PMID: 12399343] (Pubitemid 35265209)
34. Levenson M, Holland C. Statistical evaluation of suicidality in adults treated with antidepressants. In: Laughren TP, ed. Memorandum: overview for December 13 meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). Silver Spring, MD: Center for Drug Evaluation and Research, U.S. Food and Drug Administration; 2006. Accessed at www.fda.gov/ohrms/dockets/ac/06/briefing/2006- 4272b1-01-FDA.pdf on 29 September 2009.
35. Stone M, Jones ML. Clinical review: relationship between antidepressant drugs and suicidality in adults. In: Laughren TP, ed. Memorandum: overview for December 13 meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). Silver Spring, MD: Center for Drug Evaluation and Research, U.S. Food and Drug Administration; 2006. Accessed at www.fda.gov/ohrms/dockets/ac/06/briefing/2006- 4272b1-01-FDA.pdf on 29 September 2009.
36. Hammad TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol. 2006;26:203-207 [PMID: 16633153]
37. Khan A, Khan S, Kolts R, Brown WA. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160:790-792 [PMID: 12668373] (Pubitemid 41079617)
38. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005;330:385. [PMID: 15718537]
39. Saperia J, Ashby D, Gunnell D. Suicidal behaviour and SSRIs: updated meta-analysis [Letter]. BMJ. 2006;332:1453. [PMID: 16777898] (Pubitemid 44365336)
40. Committee on Safety of Medicines. Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants. London: Medicines and Healthcare products Regulatory Agency; 2004. Accessed at www.mhra.gov.uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf on 29 September 2009.
41. Briefing document: paroxetine adult suicidality analysis: major depressive disorder and non-major depressive disorder. GlaxoSmithKline; 2006. Accessed at http://us.gsk.com/docs-pdf/media-news/briefing-doc.pdf on 29 September 2009.
42. Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330:396. [PMID: 15718539]
43. Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry. 2001;158:1271-1275 [PMID: 11481162]
44. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19-36. [PMID: 10760555]
45. Arroll B, Macgillivray S, Ogston S, Reid I, Sullivan F, Williams B, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3:449-456 [PMID: 16189062] (Pubitemid 41512663)
46. Beasley CM Jr, Nilsson ME, Koke SC, Gonzales JS. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose. J Clin Psychiatry. 2000;61:722-728 [PMID: 11078032]
47. Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss A, Gaynes BN, Krebs EE, et al. Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. Comparative Effectiveness Review No. 7-EHC007-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
48. MacGillivray S, Arroll B, Hatcher S, Ogston S, Reid I, Sullivan F, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003;326:1014. [PMID: 12742924]
49. Mottram P, Wilson K, Strobl J. Antidepressants for depressed elderly. Cochrane Database Syst Rev. 2006:CD003491. [PMID: 16437456]
50. Mulrow CD, Williams JW Jr, Chiquette E, Aguilar C, Hitchcock-Noel P, Lee S, et al. Efficacy of newer medications for treating depression in primary care patients. Am J Med. 2000;108:54-64. [PMID: 11059441] (Pubitemid 30058278)
51. Williams JW Jr, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132:743-756 [PMID: 10787370] (Pubitemid 30244176)
52. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995;310:215-218 [PMID: 7677826]
53. Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ. 2005;330:389. [PMID: 15718538]
54. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41-47 [PMID: 16390887]
55. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001;286:2947-2955 [PMID: 11743835] (Pubitemid 33140358)
56. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905-1917 [PMID: 17074942] (Pubitemid 44807782)
57. Dalton SO, Sørensen HT, Johansen C. SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing? CNS Drugs. 2006;20:143-151 [PMID: 16478289]
58. de Abajo FJ, Rodríguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319:1106-1109 [PMID: 10531103] (Pubitemid 29494721)
59. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:655-658 [PMID: 11566827]
60. Dalton SO, Johansen C, Mellemkjaer L, Nørgård B, Sørensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163:59-64. [PMID: 12523917] (Pubitemid 36091601)
61. Tata LJ, Fortun PJ, Hubbard RB, Smeeth L, Hawkey CJ, Smith CJ, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther. 2005;22:175-181 [PMID: 16091054]
62. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-776 [PMID: 12020146]
63. Gilbody S, Sheldon T, Wessely S. Should we screen for depression? BMJ. 2006;332:1027-1030 [PMID: 16644833]
64. Palmer SC, Coyne JC. Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res. 2003;54:279-287 [PMID: 12670603]
65. Simon GE, VonKorff M. Recognition, management, and outcomes of depression in primary care. Arch Fam Med. 1995;4:99-105. [PMID: 7842160]
66. Goldberg D, Privett M, Ustun B, Simon G, Linden M. The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract. 1998;48:1840-1844 [PMID: 10198504] (Pubitemid 28552140)
67. Thompson C, Ostler K, Peveler RC, Baker N, Kinmonth AL. Dimensional perspective on the recognition of depressive symptoms in primary care: The Hampshire Depression Project 3. Br J Psychiatry. 2001;179:317-323 [PMID: 11581111] (Pubitemid 32996040)
68. Schwenk TL, Coyne JC, Fechner-Bates S. Differences between detected and undetected patients in primary care and depressed psychiatric patients. Gen Hosp Psychiatry. 1996;18:407-415 [PMID: 8937906] (Pubitemid 26394053)
69. Oxman TE, Sengupta A. Treatment of minor depression. Am J Geriatr Psychiatry. 2002;10:256-264 [PMID: 11994212]
70. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101-108 [PMID: 16390896] (Pubitemid 43050110)
71. Simon GE. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry. 2002;24:213-224 [PMID: 12100832]
72. Solberg LI, Trangle MA, Wineman AP. Follow-up and follow-through of depressed patients in primary care: the critical missing components of quality care. J Am Board Fam Pract. 2005;18:520-527 [PMID: 16322414]
73. Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A Jr, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003;160:2080-2090 [PMID: 14638573] (Pubitemid 39619597)
74. Gensichen J, Beyer M, Muth C, Gerlach FM, Von Korff M, Ormel J. Case management to improve major depression in primary health care: a systematic review. Psychol Med. 2006;36:7-14. [PMID: 16356292] (Pubitemid 41825341)
75. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med Care. 2004;42:1211-1221 [PMID: 15550801] (Pubitemid 39627298)
76. Williams JW Jr, Gerrity M, Holsinger T, Dobscha S, Gaynes B, Dietrich A. Systematic review of multifaceted interventions to improve depression care. Gen Hosp Psychiatry. 2007;29:91-116. [PMID: 17336659] (Pubitemid 46320683)
77. Wang PS, Simon G, Kessler RC. The economic burden of depression and the cost-effectiveness of treatment. Int J Methods Psychiatr Res. 2003;12:22-33. [PMID: 12830307] (Pubitemid 36675445)
78. Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry. 2006;163:813-821 [PMID: 16648321] (Pubitemid 44464528)
79. Barak Y, Olmer A, Aizenberg D. Antidepressants reduce the risk of suicide among elderly depressed patients. Neuropsychopharmacology. 2006;31:178-181 [PMID: 16123751] (Pubitemid 43250953)
80. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008;27:31-40. [PMID: 17919277] (Pubitemid 350212624)
81. National Collaborating Centre for Mental Health. Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline 23. 1-63. London: NICE; 2004.
82. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-1170 [PMID: 12775614] (Pubitemid 36649048)
83. Ernst CL, Goldberg JF. Antisuicide properties of psychotropic drugs: a critical review. Harv Rev Psychiatry. 2004;12:14-41. [PMID: 14965852]